GC Biopharma Corp. (KRX:006280)
South Korea · Delayed Price · Currency is KRW 152,700
-1,000 (-0.65%)
At close: Jul 25, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Manufacturing and Sales of Pharmaceuticals, Etc. | 1,440.88B | Log In | Log In | Log In | Log In | Upgrade |
Manufacturing and Sales of Pharmaceuticals, Etc. Growth | -2.94% | Log In | Log In | Log In | Log In | Upgrade |
Diagnosis and Analysis of Samples, Etc. | 213.76B | Log In | Log In | Log In | Log In | Upgrade |
Diagnosis and Analysis of Samples, Etc. Growth | -18.47% | Log In | Log In | Log In | Log In | Upgrade |
Consolidation | -46.49B | Log In | Log In | Log In | Log In | Upgrade |
Consolidation Growth | -19.06% | Log In | Log In | Log In | Log In | Upgrade |
Other | 18.50B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -16.29% | Log In | Log In | Log In | Log In | Upgrade |
Green Cross Corporation | - | Log In | Log In | Log In | Log In | Upgrade |
Green Cross Corporation Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Green Cross Medical Science Corporation | - | Log In | Log In | Log In | Log In | Upgrade |
Green Cross Medical Science Corporation Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Green Cross WellBeing Corporation | - | Log In | Log In | Log In | Log In | Upgrade |
Green Cross WellBeing Corporation Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Green Cross Lab Cell Corporation | - | Log In | Log In | Log In | Log In | Upgrade |
Green Cross Lab Cell Corporation Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Invanfarm Corporation | - | Log In | Log In | Log In | Log In | Upgrade |
Invanfarm Corporation Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Green Cross Genome Corporation | - | Log In | Log In | Log In | Log In | Upgrade |
Green Cross Genome Corporation Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Green Cross Medis Corp. | - | Log In | Log In | Log In | Log In | Upgrade |
Green Cross Medis Corp. Growth | - | Log In | Log In | Log In | Log In | Upgrade |
GCC Corporation | - | Log In | Log In | Log In | Log In | Upgrade |
GC DO Brasil Participacoes LTDA | - | Log In | Log In | Log In | Log In | Upgrade |
Consolidation | -46.49B | Log In | Log In | Log In | Log In | Upgrade |
Consolidation Growth | -19.06% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Consolidation | -46.49B | Log In | Log In | Log In | Log In | Upgrade |
Consolidation Growth | -19.06% | Log In | Log In | Log In | Log In | Upgrade |
South Korea | 1,400.27B | Log In | Log In | Log In | Log In | Upgrade |
South Korea Growth | -4.23% | Log In | Log In | Log In | Log In | Upgrade |
Overseas | 272.87B | Log In | Log In | Log In | Log In | Upgrade |
Overseas Growth | -11.03% | Log In | Log In | Log In | Log In | Upgrade |
Consolidation | -46.49B | Log In | Log In | Log In | Log In | Upgrade |
Consolidation Growth | -19.06% | Log In | Log In | Log In | Log In | Upgrade |